FindTrial
Sign In

Comparison of USG-Guided Quadratus Lumborum and Transversus Abdominis Plane Blocks for Post Operative Pain Relief in Pediatric Patients undergoing Lower Abdominal Surgery - A RANDOMISED CONTROLLED TRIAL

Comparison of USG-Guided Quadratus Lumborum and Transversus Abdominis Plane Blocks in Pediatric Patients undergoing Lower Abdominal Surgery - A RANDOMISED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049725
Enrollment
88
Registered
2023-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K669- Disorder of peritoneum, unspecified

Interventions

Intervention1: Procedure - Transverse Abdominis Plane Block: Dose - 0.5 mg/Kg of 0.25% Bupivacaine Inj Frequency - Single dose immediately post-operatively Route of Administration - In-Plane Block t

Sponsors

Praveen Rajput
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) All pediatric patients (age more than or equal years and less than or equal 12 years) undergoing lower abdominal surgery between 01 Jan 2023 to 31 Dec 2024 in a 1082-bedded tertiary care teaching hospital. (b) American Society of Anesthesiologists (ASA) Physical Status Class I and II patients (c) Every consenting pediatric patient receiving General Anesthesia plus Transverse Abdominis or Quadratus Lumborum Plane Block.

Exclusion criteria

Exclusion criteria: (a) Pediatric patients with infection at the injection site (b) Pediatric patients with allergy to local anaesthetics (c) Pediatric patients with coagulation disorders, severe obesity (BMI more than 40), and physical or mental diseases which could interfere with the evaluation of pain scores. (d) Pediatric patients with kidney failure or liver failure. (e) Pediatric patients with sepsis and chronic pain disorders that necessitate the intake of opioids at home. (f) Pediatric patients with any substantial neurological, cardiovascular, malignancy or breathing disorder.

Design outcomes

Primary

MeasureTime frame
Outcome 1. FLACC Scores for both the blocks Outcome 2. Quantitative requirement of IV PCM / Diclofenac and other narcotic Analgesics post operatively Outcome 3. Time after which analgesia is required after block administration Outcome 4. recording of Block related complications if anyTimepoint: Time point for Outcome 1. FLACC - One (01) hour, Six (06) hours, and 12 hours post-operatively Time point for outcome 2. Not Applicable Time point for Outcome 3. Duration of time after which analgesia is required after administering the block Time point for Outcome 4 - Not Applicable—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactLt Col Gunjan Singh

AFMC,Pune

drkirans@gmail.com9823464596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026